RiboBio, founded by the inventors and initial developers of siRNA, has over 15 years’ experience specializing in RNA synthesis and development. Today, RiboBio provides industry-leading CRO & CMC services for RNA-based drugs, including siRNA, ASO, mRNA, CRISPR and others. Over the past 2 years, RiboBio has fulfilled over 150 contracts globally!

RiboBio established a comprehensive oligonucleotide manufacturing facility supporting small to large scale, low to high throughput, cGMP production and a comprehensive oligonucleotide analytical lab. In 2013, RiboBio built the first cGMP oligonucleotide manufacturing facility in China and was issued the Oligo-based Drug Manufacturing Permit by CFDA in 2016.